Almaject is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules.

Company overview

Focusing on injectable generic pharmaceutical products.

Almaject

Focusing on branded pharmaceutical products.

Almatica brand products

Focusing on generic pharmaceutical products for the United States.

Alvogen generic business

In-house manufacturing capabilities include finished dosage form including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.

Norwich US-based manufacturing

Alvogen Core Businesses include:

For additional information, visit www.alvogen.com﻿